Global Information
회사소개 | 문의 | 비교리스트

생화학 분석기 및 시스템 : 체외 진단 시장 분석과 예측 모델

Clinical Chemistry Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)

리서치사 GlobalData
발행일 2020년 06월 상품 코드 640282
페이지 정보 영문
가격
US $ 7,500 ₩ 8,841,000 Excel (Single User License)
US $ 15,000 ₩ 17,682,000 Excel (Site License)
US $ 22,500 ₩ 26,523,000 Excel (Global License)


생화학 분석기 및 시스템 : 체외 진단 시장 분석과 예측 모델 Clinical Chemistry Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)
발행일 : 2020년 06월 페이지 정보 : 영문

세계 주요 39개국의 생화학 분석기 및 시스템(Clinical Chemistry - Analyzers and Systems) 시장에 대해 조사했으며, 시장 및 제품 개요, 주요 산업 동향, 설치 대수, 신규 판매량, 평균 판매 가격 등의 각종 데이터와 추정, 전자동/반자동 구분별 연간 매출 추정과 예측, 경쟁 상황과 기업 점유율, 애널리스트의 각종 분석 등의 정보를 전해드립니다.

1. 주요 조사 내용

  • 현재 시판되고 있는 제품과 경쟁 동향
  • 주요 산업 동향 리뷰
  • 연간 매출 추정과 예측 : 각종 구분별
    • 전자동
    • 반자동
  • 각종 상세 데이터
    • 설치 대수
    • 신규 판매량
    • 평균 판매 가격 등
  • 기업 점유율
  • 애널리스트의 분석

2. 본 보고서의 이점

  • 파이프라인 제품 및 기술을 리뷰하고, 강력한 파이프라인을 가진 기업을 확인하여 인 라이선싱 및 아웃 라이선싱 전략의 구축과 설계가 가능
  • 제품 시장을 형성 및 추진하는 동향을 이해하여 사업 전략 구축이 가능
  • 주요 동향, 혁신적 제품과 기술, 영향력을 가진 기업 등에 대해 이해하여 매출 촉진이 가능
  • 경쟁 상황을 이해하고, 시장 리더의 점유율을 분석하여 유효한 판매 및 마케팅 전략 구축이 가능
  • 경쟁상 우위에 서기위해 잠재력 있는 제품 포트폴리오를 가진 신흥 기업을 확인하고, 유효한 대항 전략을 구축하는 것이 가능
  • 세계 및 국가별 기기 판매 추정과 예측 추적이 가능
  • 통합, 투자, 전략적 제휴의 최대 기회를 나타내는 시장 부문 및 카테고리를 확인하여 판매와 마케팅 활동의 체계화가 가능
KSM 18.06.05

Clinical Chemistry Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact)

Clinical Chemistry Analyzers (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Clinical Chemistry Analyzers market for the year 2020 and beyond. Clinical chemistry analyzers measure a broad array of biochemical parameters including diabetic factors, tumour markers, drugs of abuse or toxicology, therapeutic drugs for monitoring, specific proteins, lipids, and chemicals such as glucose, cholesterol, waste products, electrolytes, cofactors, and enzymes.

Due to their versatility, clinical chemistry analyzers are relied upon for diagnosis and monitoring of a range of different conditions including diabetes, cancer, cardiac disease, kidney disease, and liver disease. Clinical chemistry analyzer market is being driven by rises in the prevalence numerous diseases such as diabetes, cancer, and liver disease as well as aging populations. Model covers various types of Analyzers including Automated, Semi-Automated and Integrated.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Clinical Chemistry Analyzers and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Clinical Chemistry Analyzers market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Clinical Chemistry Analyzers market.
  • Competitive dynamics insights and trends provided for Clinical Chemistry Analyzers market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: F. Hoffman-La Roche Ltd, Siemens Healthineers AG, Abbott Labs, Danaher Corp, Mindray Medical International Ltd, Randox Labs Ltd, Ortho-Clinical Diagnostics Inc and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Clinical Chemistry Analyzers market place to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Clinical Chemistry Analyzers market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Clinical Chemistry Analyzers market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Clinical Chemistry Analyzers market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Clinical Chemistry Analyzers market from 2015-2030.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Back to Top
전화 문의
F A Q